Infantile spasm drug Synacthen Depot cost-per-vial jumped by 2,000 percent. The sudden price hike caused Alberta Health to delist the drug in the government-subsidized healthcare and many health officials and families affected.
Infantile spasm drug Synacthen Depot cost-per-vial jumped by 2,000 percent. The sudden price hike caused Alberta Health to delist the drug in the government-subsidized healthcare and many health officials and families affected.